C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/21/2006	US7138248 Method of inhibiting inward rectifier, G-protein activated, mammalian, potassium channels and uses thereof
11/21/2006	US7138243 NTB-A, a surface molecule involved in natural killer cells activity
11/21/2006	US7138242 Replication primer sequences for identifying ligand-binding domains for detection of neuron odorants, toxic odors and which can be used to manipulate odor response in animals
11/21/2006	US7138240 Detection of protein receptor activity in a cell; detecting translocation of a detectable molecule from the cytosol to the membrane edge of the cell; translocation indicates receptor activity
11/21/2006	US7138238 Identifying peptide of interest; preparing peptide to be coupled to a sensor; preparing sensor to be coupled to peptide; coupling peptide to sensor; quantifying signal output from sensor; exposing sensor ligands; quantifying signal
11/21/2006	US7138237 Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
11/21/2006	US7138236 Interactions of ATM, ATR or DAN-PK with p53
11/21/2006	US7138234 Gene involved in CADASIL, method of diagnosis and therapeutic application
11/21/2006	US7138233 IN vitro sorting method
11/21/2006	US7138231 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
11/21/2006	US7138150 Expressing a nucleic acid encoding protein selected from lactoferrin protein and lysozyme protein in a monocot seed; isolating protein from the seed, combining with carrier diluent to provide formulation for oral administration
11/21/2006	US7138126 Modifying wild strain of enteroinvasive Shigella; cannot spread within infected cells and from infected to uninfected cells of the host; vaccines; deactivation by inserting transposon into gene; mutagenizing; genetically engineered by allelic exchange
11/21/2006	US7138122 Therapeutic systems
11/21/2006	US7138112 Plasmid maintenance system for antigen delivery
11/21/2006	CA2433386C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
11/21/2006	CA2398510C Tissue-specific expression of target genes in plants
11/21/2006	CA2341143C Production of motif-specific and context-independent antibodies using peptide libraries as antigens
11/21/2006	CA2201153C Monoclonal antibody to human cardiac myoglobin
11/21/2006	CA2076793C Methods and reagents for hepatitis c detection
11/21/2006	CA1341515C Hormone receptor compositions and methods
11/17/2006	CA2549902A1 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
11/16/2006	WO2006122224A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in pseudomonas aeruginosa
11/16/2006	WO2006122214A2 NOVEL STEROID 5 α -REDUCTASE
11/16/2006	WO2006122141A2 Methods and products for determining f4/80 gene expression in microglial cells
11/16/2006	WO2006122053A2 Biomarkers for evaluating likelihood of tumor sensitivity to an mtor inhibitor
11/16/2006	WO2006122050A2 Methods and compositions for detecting immune responses
11/16/2006	WO2006122023A1 Agrobacterium transformation of stolons
11/16/2006	WO2006121960A2 Methods and sequences to suppress primate huntington gene expression
11/16/2006	WO2006121951A2 Antisense antiviral compounds and methods for treating foot and mouth disease
11/16/2006	WO2006121902A2 Interaction of glyphosate with photosystem ii inhibitor herbicides as a selection tool for roundup ready events
11/16/2006	WO2006121810A2 Trimeric ox40-immunoglobulin fusion protein and methods of use
11/16/2006	WO2006121464A2 Compositions for treating respiratory viral infections and their use
11/16/2006	WO2006121178A1 Method for transformation using mutant acetolactate synthase gene
11/16/2006	WO2006121168A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
11/16/2006	WO2006121165A1 Method for producing protein
11/16/2006	WO2006121159A1 Humanized cdr-grafted antibody specifically reacting with cd10 and antibody fragment of the same
11/16/2006	WO2006121136A1 Method for determination of endoplasmic reticulum stress
11/16/2006	WO2006121134A1 Primer and probe for use in detection of mycobacterium kansasii and method for detection of mycobacterium kansasii using the same
11/16/2006	WO2006121055A1 Process for production of ϝ-glutaramide compound
11/16/2006	WO2006121047A1 Method for determination of megsin in biological sample
11/16/2006	WO2006120992A1 Nucleic acid derivatives having phenyldiaziridine moieties and process for production thereof, nucleotide derivatives having phenyldiaziridine moieties and process for production thereof, method for analysis of protein, and process for preparation of protein
11/16/2006	WO2006120455A2 Ovalbumin promoter constructs for retroviral vectors
11/16/2006	WO2006120197A2 Expression cassettes for seed-preferential expression in plants
11/16/2006	WO2006120034A1 Vaccine composition
11/16/2006	WO2006120019A2 Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions
11/16/2006	WO2006119983A2 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
11/16/2006	WO2006119965A2 Growth factor mutants with altered biological attributes
11/16/2006	WO2006119780A2 New antibiotic-sensitive lactic acid bacteria strains
11/16/2006	WO2006119647A1 Oligonucleotides and methods of use
11/16/2006	WO2006119627A1 Enhancing vegetative protein production in transgenic plants using seed specific promoters
11/16/2006	WO2006102643A3 Stably transformed bone marrow-derived cells and uses thereof
11/16/2006	WO2006088962A9 Replikin peptides and uses thereof
11/16/2006	WO2006088849A3 Metabolic-based methods for modulating gene expression
11/16/2006	WO2006073458A8 Oligonucleotides comprising a c5-modified pyrimidine
11/16/2006	WO2006071691A3 Rnai inhibition of serum amyloid a for treatment of glaucoma
11/16/2006	WO2006060595A3 Reverse two hybrid system for identification of interaction domains
11/16/2006	WO2006056590A3 Plants having increased yield and a method for making the same
11/16/2006	WO2006053245A3 Retroviral vectors with introns
11/16/2006	WO2006046152A3 Methods for heterologous expression of secondary metabolites
11/16/2006	WO2006044290A3 Biosynthesis of philoroglucinol and preparation of 1,3-dihydroxybenzene therefrom
11/16/2006	WO2006034228A3 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use
11/16/2006	WO2006027696B1 Process to obtain a molecular marker to determine the sex type in borojo plants
11/16/2006	WO2005123993A3 Phage microarray profiling of the humoral response to disease
11/16/2006	WO2005081714A3 Use of interfering rna in the production of transgenic animals
11/16/2006	WO2005072703A3 Controlled and sustained delivery of nucleic acid-based therapeutic agents
11/16/2006	WO2004058157A3 Yeast-based vaccines as immunotherapy
11/16/2006	US20060260013 Root-specific phosphate transporter promoters
11/16/2006	US20060260012 Method of transforming soybean
11/16/2006	US20060260011 Methods and genetic constructs for modification of lignin composition of corn cobs
11/16/2006	US20060260010 Increased flower size, astaxanthin content, and/or reduced cardenolide content; astaxanthin-containing Adonis oleoresin and methods of extracting astaxanthin and other ketocarotenoids from flowers of Adonis palaestina plants, while reducing non-ketocarotenoids and cardenolides
11/16/2006	US20060260009 Containing regulatory sequences whose expression results in spectrally red-shifted phytochromes that are effective in detecting far-red light in the shade; transgenic plants having shade tolerance
11/16/2006	US20060260008 vectors, transformed host cells that contain nucleic acid segments that encode the disclosed delta -endotoxin polypeptides; Bacillus thuringiensis cell
11/16/2006	US20060260007 Inhibitors of yeast filamentous growth and method of their manufacture
11/16/2006	US20060260006 Transgenic plants has DNA in its genome; nucleotide sequence encoding an enzyme to catalyze the biosynthesis of peroxisomes, biodegradable polylactone thermoplastics; transgenic oilseed crops; free of dehydrogenase activity
11/16/2006	US20060260005 Transformation of Brassica
11/16/2006	US20060260004 Par-related protein promoters
11/16/2006	US20060260003 Device and Method to Facilitate Directed Delivery and Electroporation
11/16/2006	US20060260002 Nucleic acid constructs comprising tomato plant promoter; gene expression of exogenous polynucleotide sequences in trichomes and transgenic plant cells; genetic engineering
11/16/2006	US20060260001 Method for obtaining recombinant plants of the cichorium genus and plants thus obtained
11/16/2006	US20060260000 Removal of plastid sequences by transiently expressed site-specific recombinases
11/16/2006	US20060259999 Modified nitrilases and their use in methods for the production of carboxylic acids
11/16/2006	US20060259998 Transgenic plants used as a bioreactor system
11/16/2006	US20060259997 Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
11/16/2006	US20060259994 Cathepsin-associated genetically modified nonhuman mammal
11/16/2006	US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006	US20060259248 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer
11/16/2006	US20060259247 Apparatus and method for automated protein design
11/16/2006	US20060258856 Method of isolating nucleic acids from stool samples
11/16/2006	US20060258855 High resolution analysis of genetic variation within cryptosporidium parvum
11/16/2006	US20060258848 Human antipneumococcal antibodies from non-human animals
11/16/2006	US20060258842 Fully humanized monoclonal antibodies that neutralize Bacillus anthracis lethal toxin; vaccines
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258611 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference
11/16/2006	US20060258610 Modulation of STAT 6 expression for the treatment of airway hyperresponsiveness
11/16/2006	US20060258609 Method for inhibition of lipogenesis by regulating PRP19 expression
11/16/2006	US20060258608 RNAi modulation of RSV and therapeutic uses thereof
11/16/2006	US20060258607 Ghrelin binding nucleic acids
11/16/2006	US20060258606 Transforming growth factor-beta response element decoys and methods
11/16/2006	US20060258603 Transposon-based targeting system

1 ... 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 ... 4023